22
May
2014
|
00:00
Europe/Amsterdam

BIOTRONIK Patients Granted Access to Ultra High Field Magnetic Resonance Imaging

Implantable Defibrillators Gain CE Approval for 3.0 Tesla and Full-Body MRI Scans

BERLIN, Germany, May 22, 2014 – BIOTRONIK, a leading manufacturer of cardiovascular medical technology that offers the world’s largest portfolio of ProMRI® cardiac implants, announced CE approval today of its ProMRI® technology for ultra high field 3.0 tesla (T) and full-body magnetic resonance imaging (MRI) with the standard 1.5 T scan strength.

BIOTRONIK is the first company worldwide to gain CE approval for patients with cardiac devices to undergo 3.0 T MRI scans, enabling physicians to receive higher image quality scans more quickly, thereby lessening examination time for patients and making the results all the more useful. Single-chamber and DX implantable defibrillators (ICDs) with atrial diagnostics are now approved with backwards compatibility for ultra high field 3.0 T scans with an exclusion zone.1 Having undergone extensive research and development, BIOTRONIK ICDs that have already been implanted are now approved for use with MRIs.

  1. 3.0 T scans are approved for Ilesto, Iforia, and Idova single-chamber and DX ICDs with LinoxSmart and Protego ProMRI® leads with an exclusion zone.
  2. Full-body 1.5 T scans are available with Ilesto and Iforia single-chamber, dual-chamber and DX ICDs with Safio S and LinoxSmart ProMRI® leads.
  3. Kalin and Stanton, Pacing and Clinical Electrophysiology (2005), 28: 326-328.
  4. Data on file.

About BIOTRONIK:

BIOTRONIK is a leading medical device company that has been developing trusted and innovative cardiovascular and endovascular solutions for more than 50 years. Driven by a purpose to perfectly match technology with the human body, BIOTRONIK innovations deliver care that saves and improves the lives of millions diagnosed with heart and blood vessel diseases every year. BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries.